Skip to main content
eScholarship
Open Access Publications from the University of California

SUMO Modification of Huntingtin and Huntington's Disease Pathology

  • Author(s): Steffan, JS
  • Agrawal, N
  • Pallos, J
  • Rockabrand, E
  • Trotman, LC
  • Slepko, N
  • Illes, K
  • Lukacsovich, T
  • Zhu, YZ
  • Cattaneo, E
  • Pandolfi, PP
  • Thompson, LM
  • Marsh, JL
  • et al.
Abstract

Huntington's disease (HD) is characterized by the accumulation of a pathogenic protein, Huntingtin (Htt), that contains an abnormal polyglutamine expansion. Here, we report that a pathogenic fragment of Htt (Httex1p) can be modified either by small ubiquitin-like modifier (SUMO)-1 or by ubiquitin on identical lysine residues. In cultured cells, SUMOylation stabilizes Httex1p, reduces its ability to form aggregates, and promotes its capacity to repress transcription. In a Drosophila model of HD, SUMOylation of Httex1p exacerbates neurodegeneration, whereas ubiquitination of Httex1p abrogates neurodegeneration. Lysine mutations that prevent both SUMOylation and ubiquitination of Httex1p reduce HD pathology, indicating that the contribution of SUMOylation to HD pathology extends beyond preventing Htt ubiquitination and degradation.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Main Content
Current View